TOPLINE: Patients who received eye injections of anti-VEGF agents around the time of a stroke or myocardial infarction did not have an increased risk for mortality or major complications, and outcomes did not vary among commonly used anti-VEGF drugs. METHODOLOGY: - Researchers conducted a retrospective cohort study using data from electronic health records from a large US network (2005-2025) to as...